Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
Contacts
Baltimore
+1 410 559 2881Baltimore
2850 Quarry Lake Drive, Suite 301
Baltimore, MD 21209
Capabilities
Suggested News & Insights
盛德助力星源材质于香港联交所主板成功上市June 23, 2026盛德助力华健未来成功完成香港18A章项下上市项目June 23, 2026Life Sciences Transactions Partners Lila Hope and Jennifer Raab Join Sidley, Accelerating Further Growth in Life Sciences and the Palo Alto OfficeJune 22, 2026Sidley Represents Yum China Holdings in US$1.2 Billion Acquisition of Pizza Hut Brand in Mainland ChinaJune 16, 2026Sidley Represents Wafra in US$1.9 Billion Acquisition of NavitasJune 12, 2026AI Collaborations – From Strategic License to Strategic AcquisitionJune 10, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory